| Title: | A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes |
| Journal: | Cancers |
| Published: | 2 Jul 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/35805029/ |
| DOI: | https://doi.org/10.3390/cancers14133257 |
| URL: | https://www.mdpi.com/2072-6694/14/13/3257/pdf?version=1656997736 |
| Citations: | 12 (10 in last 2 years) as of 8 Aug 2024 |
Publication 10348
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Patients with germline pathogenic variants (GPV) in cancer predisposition genes are at increased risk of pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer. The genes most frequently found to harbor GPV in unselected PDAC cases are ATM, BRCA1, BRCA2, CDKN2A, CHEK2, and PALB2. However, GPV prevalence and gene-specific associations have not been extensively studied in the general population. To further explore these associations, we analyzed genomic and phenotypic data obtained from the UK Biobank (UKB) and Geisinger MyCode Community Health Initiative (GHS) cohorts comprising 200,600 and 175,449 participants, respectively. We estimated the frequency and calculated relative risks (RRs) of heterozygotes in both cohorts and a subset of individuals with PDAC. The combined frequency of heterozygous carriers of GPV in the general population ranged from 1.22% for CHEK2 to 0.05% for CDKN2A. The frequency of GPV in PDAC cases varied from 2.38% (ATM) to 0.19% (BRCA1 and CDKN2A). The RRs of PDAC were elevated for all genes except for BRCA1 and varied widely by gene from high (ATM) to low (CHEK2, BRCA2). This work expands our understanding of the frequencies of GPV heterozygous carriers and associations between PDAC and GPV in several important PDAC susceptibility genes.</p>
9 Authors
- Esteban Astiazaran-Symonds
- Jung Kim
- Jeremy S. Haley
- Sun Young Kim
- H. Shanker Rao
- Regeneron Genetics Center
- David J. Carey
- Douglas R. Stewart
- Alisa M. Goldstein
1 Application
| Application ID | Title |
|---|---|
| 54389 | Frequency, phenotypic spectrum, and penetrance of pathogenic variation in cancer susceptibility genes in the general population |
Enabling scientific discoveries that improve human health